AKT1 and neoplasm: Several studies demonstrated that these TKIs inhibit IGF-IR/IR phosphorylation and AKT activation, and consequently lead to increased apoptosis, decreased in vitro cell proliferation, and tumor suppression in xenografts models (Serra et al., 2008; Carboni et al., 2009).